The Capability of GPT-4o in Predicting Consumer Choice Read our latest whitepaper

Marketing Advisory, Strategy and Analytics
  • About us
  • What we do
    • Solutions
    • Industries
  • Our work
  • Our thinking
  • Join us
  • Speak to Forethought
  • About us
  • What we do
    • Solutions
    • Industries
  • Our work
  • Our thinking
  • Join us
  • Speak to Forethought
Filter by
  • All
  • APAC
  • Analytics
  • B2B
  • Brand Strategy
  • Creative Efficacy
  • Customer Experience
  • Engagement
  • Media
  • Offer Optimisation

Showing 51-53 of 53 results:

  • Independent Vaccination Ads motivate higher levels of Vaccine action than Federal Government’s attempts
    Creative Efficacy

    Independent Vaccination Ads motivate higher levels of Vaccine action than Federal Government’s attempts

    Forethought’s latest ad tests have revealed a far greater impact on respondent likelihood to book a vaccination from the recently released ‘Back to the Good Things’ and ‘Performance of a Lifetime’ ads, as opposed to the Federal Government’s ‘Arm Yourself’ and ‘ICU – Breathless’ campaigns.

  • Forethought Mind and Mood Pulse – June/July 2021
    Analytics, Customer Experience, Creative Efficacy

    Forethought Mind and Mood Pulse – June/July 2021

    Forethought has been observing the increasing stability of Australian’s sense of Normality since March 2020 and hypothesising that we had achieved ‘The New Normal’, when the NSW infection rates started to climb rapidly.

  • Forethought Mind and Mood Pulse – April 2021
    Analytics, Customer Experience, Creative Efficacy

    Forethought Mind and Mood Pulse – April 2021

    Forethought launched the Normality Index (NI) immediately as we went into lockdown in March 2020. We now have 21 waves of data (weekly for the first 12 weeks and now monthly since July 2020). Here are the key findings from our April pulse.

3 4 5 6

Footer

Marketing Advisory, Strategy and Analytics

  • Homepage
  • About us
  • Solutions
  • Our work
  • Industries
  • Our thinking
  • Join us
  • Speak to Forethought
  • Legal Notices

Join Our Mailing List

Sign-up here to learn more about our latest news, white papers and articles.

Server Error. Please try again later.

You have been successfully subscribed!

© 2025 Forethought Outcomes, Inc. All rights reserved.
Site by